『Wrestling the Octopus IBD』のカバーアート

Wrestling the Octopus IBD

Wrestling the Octopus IBD

著者: Rachel Sawyer (The Bottom Line IBD) and Nigel Horwood
無料で聴く

プレミアムプランが3か月 月額99円

登録で500円分のAmazonギフトカードプレゼント。12月23日まで。※適用条件あり
概要

Two long-term IBD patients, Rachel and Nigel, share their experiences and perspectives on living with inflammatory bowel disease (Crohn's disease and ulcerative colitis).

© 2026 Wrestling the Octopus IBD
衛生・健康的な生活 身体的病い・疾患
エピソード
  • #47 Fatigue in IBD: is Vitamin B1 a potential solution? - with Dr Palle Bager
    2026/11/22

    Send us Fan Mail

    Fatigue is one of the most common yet least understood symptoms of inflammatory bowel disease (IBD). In this episode of Wrestling the Octopus: The IBD Patient Podcast, we are joined by Danish clinical nurse specialist and researcher, Dr Palle Bager to explore why fatigue affects so many people living with Crohn's disease and ulcerative colitis, even when our disease appears to be under control.

    Drawing on more than asolutio decade of research, Dr Bager discusses the many factors that may contribute to fatigue, from inflammation and nutrient deficiencies to sleep, mental wellbeing and the wider realities of living with a chronic illness.

    Topics covered include:

    • Why fatigue can persist even when IBD is in remission

    • The links between fatigue, inflammation, anaemia, iron deficiency and vitamin deficiencies

    • Why Crohn's disease patients may be at greater risk of certain nutritional deficiencies

    • How clinicians investigate fatigue and the importance of patient-centred care

    • The psychological impact of fatigue, including guilt, social isolation and unmet expectations

    • Dr Bager's research into high-dose thiamine (vitamin B1) as a potential treatment for severe fatigue

    • What the thiamine trial found and the theory behind how it may work

    • Why patients should speak to their healthcare team before considering thiamine supplementation

    • The current evidence for other fatigue treatments, including modafinil

    • The role of exercise, sleep and lifestyle interventions in managing fatigue

    • Blood sugar, nutrition and gut health, and how eating patterns may influence energy levels

    • The challenge of living with an invisible illness and communicating fatigue to others

    • Why fatigue is now recognised within the latest STRIDE-3 treatment targets for inflammatory bowel disease

    Whether you are living with inflammatory bowel disease or supporting someone who is, this episode offers practical insights, emerging research and a compassionate discussion about one of the most significant quality-of-life issues facing people with IBD.

    Follow Rachel at @bottomlineibd

    Follow Nigel at @crohnoid

    続きを読む 一部表示
    38 分
  • #46 Understanding GLP-1 drugs in IBD - with Dr David Rubin, University of Chicago
    2026/11/08

    Send us Fan Mail

    GLP-1 drugs have transformed the conversation around weight loss, but could they also play a role in managing inflammatory bowel disease (IBD)? In this episode of Wrestling the Octopus IBD, we are joined by a world leader in gastroenterology, Dr David Rubin, professor of gastroenterology, hepatology and nutrition at the University of Chicago. He educates our listeners on what these medications could mean for people living with Crohn's disease and ulcerative colitis.

    Dr Rubin explains how GLP-1 drugs work beyond appetite suppression, including their effects on gut motility, metabolism, inflammation and overall gut health. The discussion looks at why obesity and excess body fat have become increasingly common in people with IBD, and how reducing inflammation associated with fat tissue may potentially benefit long-term health.

    The conversation explores emerging research into GLP-1 drugs such as semaglutide and tirzepatide, including studies investigating whether they may help reduce intestinal inflammation alongside traditional IBD treatments. Dr Rubin shares insights from his own clinical practice, where these medications are already being used in selected patients with Crohn's disease and ulcerative colitis.

    One of the most fascinating themes in this episode is the emerging field of immunometabolic health. Dr Rubin explains how metabolism, body fat and the immune system are closely connected, and why improving metabolic health may help reduce inflammation in people with Crohn's disease and ulcerative colitis. The discussion explores whether GLP-1 drugs could offer benefits beyond weight loss, potentially becoming part of a broader approach to inflammatory bowel disease care.

    Dr Rubin also discusses important practical considerations, including side effects, nutritional monitoring, exercise, muscle loss and the need for careful medical supervision. The episode addresses who may benefit from GLP-1 treatment, who may need additional caution and why symptom improvement does not necessarily mean underlying inflammatory bowel disease is under control.

    Along the way, the discussion covers rapid gut transit in people with ileostomies and J-pouches, mesenteric fat, intestinal ultrasound, immunometabolic health and why comprehensive care should focus on the whole person, not just the bowel. There is even time for a lively diversion into bile acid malabsorption, one of Nigel's favourite topics.

    Whether you are considering GLP-1 drugs for weight loss, curious about the latest Crohn's disease and ulcerative colitis research or interested in the future of gut health and IBD care, this episode offers a balanced and evidence-based look at one of the most talked-about developments in gastroenterology.

    In this episode:

    • Why GLP-1 drugs are generating so much interest in IBD
    • How GLP-1 medications affect appetite, digestion and gut motility
    • The links between obesity, inflammation and inflammatory bowel disease
    • Whether GLP-1 drugs may help people with Crohn's disease and ulcerative colitis
    • Current research into semaglutide, tirzepatide and IBD
    • Potential benefits for people with ileostomies and J-pouches
    • Side effects, safety considerations and monitoring
    • The importance of nutrition, exercise and preserving muscle mass
    • New developments in intestinal ultrasound and personalised IBD care
    • What the next five years of GLP-1 and gut health research might look like

    Follow Rachel at @bottomlineibd

    Follow Nigel at @crohnoid

    続きを読む 一部表示
    43 分
  • #45 Treating pain in IBD - with Dr Jessica Sheehan from University of Michigan Health
    2026/11/01

    Send us Fan Mail

    Living with pain is a common and debilitating aspect of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. In this episode of Wrestling the Octopus IBD, we are joined by Dr Jessica Sheehan, IBD specialist at the University of Michigan Health in Ann Arbor. She gives us excellent advice on how IBD patients can manage pain.

    Dr Sheehan explains that abdominal pain does not always mean your IBD is flaring. While active inflammation can certainly cause pain, symptoms may also arise from complications such as strictures, infections, fistulas or changes in how the gut and nervous system process pain signals.

    A major focus of the discussion is visceral hypersensitivity and central sensitisation, where the gut and brain become more sensitive to pain after repeated periods of inflammation. This can leave some people with significant symptoms despite normal tests and well-controlled disease. [

    The conversation also challenges common misconceptions about pain in Crohn's and ulcerative colitis. Dr Sheehan explains that the gastrointestinal tract contains an extensive nervous system and that pain can result from stretching, distension, gas and other stimuli, not just active inflammation.

    Pain Management Options Discussed

    The episode explores a range of pain management approaches, including:

    • Treating underlying inflammation where present
    • Appropriate use of paracetamol and discussion of evolving views on NSAIDs
    • Medications used for chronic pain sensitisation
    • Low FODMAP dietary approaches for IBS-like symptoms in quiescent Crohn's disease
    • Working with specialist dietitians to support gut health
    • Gut-directed cognitive behavioural therapy and other psychological therapies
    • Improving sleep and addressing fatigue
    • Acupuncture and other complementary approaches
    • Pelvic floor assessment and therapy where appropriate

    Dr Sheehan emphasises that effective pain care often requires a multidisciplinary approach involving gastroenterologists, dietitians, psychologists and other specialists working together.

    Key Message for Patients

    One of the most powerful messages from this episode is that pain remains real, even when tests look normal. Dr Sheehan encourages patients not to feel dismissed if inflammation is under control but symptoms remain. Instead, she advocates for ongoing conversations about symptoms, quality of life and treatment options, highlighting the importance of patient-centred care.

    Looking Ahead

    Dr Sheehan also shares details of upcoming research aimed at identifying which patients are most likely to continue experiencing abdominal pain after their inflammation improves. The hope is that earlier identification will allow clinicians to introduce supportive therapies sooner and improve long-term outcomes for people living with Crohn's disease, ulcerative colitis and other forms of inflammatory bowel disease.

    If you live with IBD and struggle with ongoing pain, this episode offers reassurance, practical insights and a hopeful look at how understanding of pain in inflammatory bowel disease continues to evolve.

    Watch Dr Sheehan's IBD School YouTube video on IBD and pain.

    Follow Rachel at @bottomlineibd

    Follow Nigel at @crohnoid

    続きを読む 一部表示
    27 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません